Analysts have been eager to weigh in on the Healthcare sector with new ratings on Viewray (VRAY) and Tiziana Life Sciences (TLSA).
Viewray (VRAY)
BTIG analyst Marie Thibault maintained a Hold rating on Viewray today. The company’s shares closed last Thursday at $3.82.
According to TipRanks.com, Thibault is a 5-star analyst with an average return of 61.7% and a 72.7% success rate. Thibault covers the Healthcare sector, focusing on stocks such as Establishment Labs Holdings, Varian Medical Systems, and Irhythm Technologies.
Viewray has an analyst consensus of Strong Buy, with a price target consensus of $4.00.
See today’s analyst top recommended stocks >>
Tiziana Life Sciences (TLSA)
B.Riley Financial analyst Mayank Mamtani maintained a Buy rating on Tiziana Life Sciences today and set a price target of $8.00. The company’s shares closed last Monday at $2.38, close to its 52-week low of $0.62.
According to TipRanks.com, Mamtani is a 5-star analyst with an average return of 29.4% and a 48.8% success rate. Mamtani covers the Healthcare sector, focusing on stocks such as Arrowhead Pharmaceuticals, Spectrum Pharmaceuticals, and Madrigal Pharmaceuticals.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Tiziana Life Sciences with a $8.00 average price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
